nodes	percent_of_prediction	percent_of_DWPC	metapath
Gallamine Triethiodide—Goitre—Sibutramine—obesity	0.0113	0.0186	CcSEcCtD
Gallamine Triethiodide—Bone marrow depression—Cimetidine—obesity	0.0112	0.0184	CcSEcCtD
Gallamine Triethiodide—Serum sickness—Bupropion—obesity	0.00751	0.0123	CcSEcCtD
Gallamine Triethiodide—Abdominal pain upper—Phendimetrazine—obesity	0.0074	0.0122	CcSEcCtD
Gallamine Triethiodide—Eruption—Sibutramine—obesity	0.00656	0.0108	CcSEcCtD
Gallamine Triethiodide—Hypothyroidism—Orlistat—obesity	0.0065	0.0107	CcSEcCtD
Gallamine Triethiodide—Upset stomach—Orlistat—obesity	0.00637	0.0105	CcSEcCtD
Gallamine Triethiodide—Hypothyroidism—Sibutramine—obesity	0.00629	0.0103	CcSEcCtD
Gallamine Triethiodide—Polyp—Bupropion—obesity	0.00579	0.00951	CcSEcCtD
Gallamine Triethiodide—Upset stomach—Bupropion—obesity	0.00537	0.00883	CcSEcCtD
Gallamine Triethiodide—Cyst—Bupropion—obesity	0.00527	0.00866	CcSEcCtD
Gallamine Triethiodide—Blood disorder—Orlistat—obesity	0.00499	0.00821	CcSEcCtD
Gallamine Triethiodide—Abdominal discomfort—Diethylpropion—obesity	0.00478	0.00785	CcSEcCtD
Gallamine Triethiodide—Pancytopenia—Diethylpropion—obesity	0.00473	0.00778	CcSEcCtD
Gallamine Triethiodide—Neoplasm malignant—Sibutramine—obesity	0.00473	0.00777	CcSEcCtD
Gallamine Triethiodide—Pancytopenia—Cimetidine—obesity	0.0045	0.0074	CcSEcCtD
Gallamine Triethiodide—Eyelid oedema—Topiramate—obesity	0.00444	0.00731	CcSEcCtD
Gallamine Triethiodide—Tachycardia—Methamphetamine—obesity	0.00442	0.00728	CcSEcCtD
Gallamine Triethiodide—Tachycardia—Benzphetamine—obesity	0.00427	0.00702	CcSEcCtD
Gallamine Triethiodide—Salivary hypersecretion—Sibutramine—obesity	0.00392	0.00645	CcSEcCtD
Gallamine Triethiodide—Gastrointestinal disorder—Methamphetamine—obesity	0.00391	0.00644	CcSEcCtD
Gallamine Triethiodide—Tachycardia—Phendimetrazine—obesity	0.00389	0.00639	CcSEcCtD
Gallamine Triethiodide—Gastrointestinal disorder—Benzphetamine—obesity	0.00377	0.00621	CcSEcCtD
Gallamine Triethiodide—Neoplasm—Orlistat—obesity	0.00377	0.0062	CcSEcCtD
Gallamine Triethiodide—Neoplasm—Sibutramine—obesity	0.00365	0.006	CcSEcCtD
Gallamine Triethiodide—Urticaria—Methamphetamine—obesity	0.0036	0.00592	CcSEcCtD
Gallamine Triethiodide—Urticaria—Benzphetamine—obesity	0.00347	0.00571	CcSEcCtD
Gallamine Triethiodide—Lymphadenopathy—Sibutramine—obesity	0.00343	0.00565	CcSEcCtD
Gallamine Triethiodide—Confusional state—Phenylpropanolamine—obesity	0.00343	0.00564	CcSEcCtD
Gallamine Triethiodide—Upset stomach—Topiramate—obesity	0.00342	0.00563	CcSEcCtD
Gallamine Triethiodide—Salivary hypersecretion—Bupropion—obesity	0.00342	0.00562	CcSEcCtD
Gallamine Triethiodide—Chest pain—Phentermine—obesity	0.0034	0.00559	CcSEcCtD
Gallamine Triethiodide—Hypersensitivity—Methamphetamine—obesity	0.00334	0.00549	CcSEcCtD
Gallamine Triethiodide—Bone marrow depression—Topiramate—obesity	0.00332	0.00546	CcSEcCtD
Gallamine Triethiodide—Tachycardia—Phenylpropanolamine—obesity	0.00332	0.00546	CcSEcCtD
Gallamine Triethiodide—Hypersensitivity—Benzphetamine—obesity	0.00322	0.0053	CcSEcCtD
Gallamine Triethiodide—Neoplasm—Bupropion—obesity	0.00318	0.00523	CcSEcCtD
Gallamine Triethiodide—Tachycardia—Phentermine—obesity	0.00318	0.00523	CcSEcCtD
Gallamine Triethiodide—Abdominal pain—Phendimetrazine—obesity	0.00315	0.00518	CcSEcCtD
Gallamine Triethiodide—Malaise—Diethylpropion—obesity	0.00313	0.00515	CcSEcCtD
Gallamine Triethiodide—Leukopenia—Diethylpropion—obesity	0.00311	0.00511	CcSEcCtD
Gallamine Triethiodide—Diarrhoea—Methamphetamine—obesity	0.0031	0.0051	CcSEcCtD
Gallamine Triethiodide—Lymphadenopathy—Bupropion—obesity	0.00299	0.00492	CcSEcCtD
Gallamine Triethiodide—Diarrhoea—Benzphetamine—obesity	0.00299	0.00492	CcSEcCtD
Gallamine Triethiodide—Malaise—Cimetidine—obesity	0.00298	0.0049	CcSEcCtD
Gallamine Triethiodide—Leukopenia—Cimetidine—obesity	0.00296	0.00486	CcSEcCtD
Gallamine Triethiodide—Chest pain—Diethylpropion—obesity	0.00296	0.00486	CcSEcCtD
Gallamine Triethiodide—Gastrointestinal haemorrhage—Sibutramine—obesity	0.00293	0.00482	CcSEcCtD
Gallamine Triethiodide—Headache—Methamphetamine—obesity	0.00284	0.00467	CcSEcCtD
Gallamine Triethiodide—Arthralgia—Cimetidine—obesity	0.00281	0.00462	CcSEcCtD
Gallamine Triethiodide—Gastrointestinal disorder—Phentermine—obesity	0.00281	0.00462	CcSEcCtD
Gallamine Triethiodide—Fatigue—Phentermine—obesity	0.00281	0.00462	CcSEcCtD
Gallamine Triethiodide—Feeling abnormal—Phenylpropanolamine—obesity	0.0028	0.00461	CcSEcCtD
Gallamine Triethiodide—Abdominal pain upper—Orlistat—obesity	0.00277	0.00455	CcSEcCtD
Gallamine Triethiodide—Tachycardia—Diethylpropion—obesity	0.00277	0.00455	CcSEcCtD
Gallamine Triethiodide—Headache—Benzphetamine—obesity	0.00274	0.0045	CcSEcCtD
Gallamine Triethiodide—Diarrhoea—Phendimetrazine—obesity	0.00273	0.00448	CcSEcCtD
Gallamine Triethiodide—Confusional state—Cimetidine—obesity	0.00272	0.00447	CcSEcCtD
Gallamine Triethiodide—Endocrine disorder—Topiramate—obesity	0.00271	0.00445	CcSEcCtD
Gallamine Triethiodide—Thrombocytopenia—Cimetidine—obesity	0.00264	0.00434	CcSEcCtD
Gallamine Triethiodide—Tachycardia—Cimetidine—obesity	0.00263	0.00433	CcSEcCtD
Gallamine Triethiodide—Nausea—Benzphetamine—obesity	0.0026	0.00427	CcSEcCtD
Gallamine Triethiodide—Sensory loss—Topiramate—obesity	0.00259	0.00426	CcSEcCtD
Gallamine Triethiodide—Urticaria—Phentermine—obesity	0.00259	0.00425	CcSEcCtD
Gallamine Triethiodide—Musculoskeletal discomfort—Diethylpropion—obesity	0.00258	0.00424	CcSEcCtD
Gallamine Triethiodide—Abdominal pain—Phentermine—obesity	0.00257	0.00423	CcSEcCtD
Gallamine Triethiodide—Gastrointestinal haemorrhage—Bupropion—obesity	0.00255	0.0042	CcSEcCtD
Gallamine Triethiodide—Abdominal discomfort—Orlistat—obesity	0.00251	0.00413	CcSEcCtD
Gallamine Triethiodide—Eosinophilia—Sibutramine—obesity	0.00251	0.00412	CcSEcCtD
Gallamine Triethiodide—Hypersensitivity—Phenylpropanolamine—obesity	0.00251	0.00412	CcSEcCtD
Gallamine Triethiodide—Headache—Phendimetrazine—obesity	0.0025	0.0041	CcSEcCtD
Gallamine Triethiodide—Musculoskeletal discomfort—Cimetidine—obesity	0.00246	0.00404	CcSEcCtD
Gallamine Triethiodide—Gastrointestinal disorder—Diethylpropion—obesity	0.00245	0.00402	CcSEcCtD
Gallamine Triethiodide—Nausea—Phendimetrazine—obesity	0.00237	0.00389	CcSEcCtD
Gallamine Triethiodide—Asthenia—Phentermine—obesity	0.00234	0.00384	CcSEcCtD
Gallamine Triethiodide—Feeling abnormal—Diethylpropion—obesity	0.00233	0.00384	CcSEcCtD
Gallamine Triethiodide—Abdominal pain upper—Bupropion—obesity	0.00233	0.00384	CcSEcCtD
Gallamine Triethiodide—Fatigue—Cimetidine—obesity	0.00232	0.00382	CcSEcCtD
Gallamine Triethiodide—Nasopharyngitis—Bupropion—obesity	0.00228	0.00376	CcSEcCtD
Gallamine Triethiodide—Urticaria—Diethylpropion—obesity	0.00225	0.0037	CcSEcCtD
Gallamine Triethiodide—Diarrhoea—Phentermine—obesity	0.00223	0.00366	CcSEcCtD
Gallamine Triethiodide—Feeling abnormal—Cimetidine—obesity	0.00222	0.00365	CcSEcCtD
Gallamine Triethiodide—Salivary hypersecretion—Topiramate—obesity	0.00218	0.00358	CcSEcCtD
Gallamine Triethiodide—Vomiting—Phenylpropanolamine—obesity	0.00216	0.00356	CcSEcCtD
Gallamine Triethiodide—Rash—Phenylpropanolamine—obesity	0.00215	0.00353	CcSEcCtD
Gallamine Triethiodide—Dermatitis—Phenylpropanolamine—obesity	0.00214	0.00353	CcSEcCtD
Gallamine Triethiodide—Body temperature increased—Cimetidine—obesity	0.00213	0.0035	CcSEcCtD
Gallamine Triethiodide—Abdominal discomfort—Bupropion—obesity	0.00212	0.00348	CcSEcCtD
Gallamine Triethiodide—Haemoglobin—Orlistat—obesity	0.00211	0.00346	CcSEcCtD
Gallamine Triethiodide—Pancytopenia—Bupropion—obesity	0.0021	0.00345	CcSEcCtD
Gallamine Triethiodide—Haemorrhage—Orlistat—obesity	0.00209	0.00344	CcSEcCtD
Gallamine Triethiodide—Vomiting—Phentermine—obesity	0.00207	0.00341	CcSEcCtD
Gallamine Triethiodide—Rash—Phentermine—obesity	0.00205	0.00338	CcSEcCtD
Gallamine Triethiodide—Dermatitis—Phentermine—obesity	0.00205	0.00337	CcSEcCtD
Gallamine Triethiodide—Headache—Phentermine—obesity	0.00204	0.00335	CcSEcCtD
Gallamine Triethiodide—Haemoglobin—Sibutramine—obesity	0.00204	0.00335	CcSEcCtD
Gallamine Triethiodide—Rhinitis—Sibutramine—obesity	0.00203	0.00334	CcSEcCtD
Gallamine Triethiodide—Haemorrhage—Sibutramine—obesity	0.00203	0.00333	CcSEcCtD
Gallamine Triethiodide—Neoplasm—Topiramate—obesity	0.00203	0.00333	CcSEcCtD
Gallamine Triethiodide—Nausea—Phenylpropanolamine—obesity	0.00202	0.00332	CcSEcCtD
Gallamine Triethiodide—Hypoaesthesia—Sibutramine—obesity	0.00202	0.00332	CcSEcCtD
Gallamine Triethiodide—Hypersensitivity—Cimetidine—obesity	0.00199	0.00327	CcSEcCtD
Gallamine Triethiodide—Diarrhoea—Diethylpropion—obesity	0.00194	0.00319	CcSEcCtD
Gallamine Triethiodide—Nausea—Phentermine—obesity	0.00193	0.00318	CcSEcCtD
Gallamine Triethiodide—Asthenia—Cimetidine—obesity	0.00193	0.00318	CcSEcCtD
Gallamine Triethiodide—Lymphadenopathy—Topiramate—obesity	0.00191	0.00314	CcSEcCtD
Gallamine Triethiodide—Eye disorder—Sibutramine—obesity	0.00189	0.00312	CcSEcCtD
Gallamine Triethiodide—Diarrhoea—Cimetidine—obesity	0.00184	0.00303	CcSEcCtD
Gallamine Triethiodide—Vomiting—Diethylpropion—obesity	0.0018	0.00296	CcSEcCtD
Gallamine Triethiodide—Rash—Diethylpropion—obesity	0.00179	0.00294	CcSEcCtD
Gallamine Triethiodide—Dysgeusia—Orlistat—obesity	0.00179	0.00294	CcSEcCtD
Gallamine Triethiodide—Dermatitis—Diethylpropion—obesity	0.00178	0.00293	CcSEcCtD
Gallamine Triethiodide—Haemoglobin—Bupropion—obesity	0.00178	0.00292	CcSEcCtD
Gallamine Triethiodide—Headache—Diethylpropion—obesity	0.00177	0.00292	CcSEcCtD
Gallamine Triethiodide—Rhinitis—Bupropion—obesity	0.00177	0.00291	CcSEcCtD
Gallamine Triethiodide—Haemorrhage—Bupropion—obesity	0.00177	0.00291	CcSEcCtD
Gallamine Triethiodide—Hypoaesthesia—Bupropion—obesity	0.00176	0.00289	CcSEcCtD
Gallamine Triethiodide—Dysgeusia—Sibutramine—obesity	0.00173	0.00284	CcSEcCtD
Gallamine Triethiodide—Vomiting—Cimetidine—obesity	0.00171	0.00282	CcSEcCtD
Gallamine Triethiodide—Rash—Cimetidine—obesity	0.0017	0.0028	CcSEcCtD
Gallamine Triethiodide—Dermatitis—Cimetidine—obesity	0.0017	0.00279	CcSEcCtD
Gallamine Triethiodide—Headache—Cimetidine—obesity	0.00169	0.00278	CcSEcCtD
Gallamine Triethiodide—Nausea—Diethylpropion—obesity	0.00168	0.00277	CcSEcCtD
Gallamine Triethiodide—Angioedema—Orlistat—obesity	0.00167	0.00274	CcSEcCtD
Gallamine Triethiodide—Eye disorder—Bupropion—obesity	0.00165	0.00272	CcSEcCtD
Gallamine Triethiodide—Malaise—Orlistat—obesity	0.00164	0.0027	CcSEcCtD
Gallamine Triethiodide—Cardiac disorder—Bupropion—obesity	0.00164	0.0027	CcSEcCtD
Gallamine Triethiodide—Anaemia—Sibutramine—obesity	0.00163	0.00268	CcSEcCtD
Gallamine Triethiodide—Angioedema—Sibutramine—obesity	0.00161	0.00265	CcSEcCtD
Gallamine Triethiodide—Nausea—Cimetidine—obesity	0.0016	0.00263	CcSEcCtD
Gallamine Triethiodide—Malaise—Sibutramine—obesity	0.00159	0.00262	CcSEcCtD
Gallamine Triethiodide—Cough—Orlistat—obesity	0.00159	0.00262	CcSEcCtD
Gallamine Triethiodide—Leukopenia—Sibutramine—obesity	0.00158	0.0026	CcSEcCtD
Gallamine Triethiodide—Chest pain—Orlistat—obesity	0.00155	0.00255	CcSEcCtD
Gallamine Triethiodide—Unspecified disorder of skin and subcutaneous tissue—Orlistat—obesity	0.00154	0.00254	CcSEcCtD
Gallamine Triethiodide—Cough—Sibutramine—obesity	0.00154	0.00253	CcSEcCtD
Gallamine Triethiodide—Dysgeusia—Bupropion—obesity	0.00151	0.00248	CcSEcCtD
Gallamine Triethiodide—Chest pain—Sibutramine—obesity	0.0015	0.00247	CcSEcCtD
Gallamine Triethiodide—Arthralgia—Sibutramine—obesity	0.0015	0.00247	CcSEcCtD
Gallamine Triethiodide—Abdominal pain upper—Topiramate—obesity	0.00149	0.00244	CcSEcCtD
Gallamine Triethiodide—Nasopharyngitis—Topiramate—obesity	0.00146	0.00239	CcSEcCtD
Gallamine Triethiodide—Confusional state—Sibutramine—obesity	0.00145	0.00239	CcSEcCtD
Gallamine Triethiodide—Skin disorder—Orlistat—obesity	0.00145	0.00238	CcSEcCtD
Gallamine Triethiodide—Anaemia—Bupropion—obesity	0.00142	0.00234	CcSEcCtD
Gallamine Triethiodide—Thrombocytopenia—Sibutramine—obesity	0.00141	0.00232	CcSEcCtD
Gallamine Triethiodide—Angioedema—Bupropion—obesity	0.00141	0.00231	CcSEcCtD
Gallamine Triethiodide—Tachycardia—Sibutramine—obesity	0.00141	0.00231	CcSEcCtD
Gallamine Triethiodide—Skin disorder—Sibutramine—obesity	0.0014	0.0023	CcSEcCtD
Gallamine Triethiodide—Eosinophilia—Topiramate—obesity	0.00139	0.00229	CcSEcCtD
Gallamine Triethiodide—Malaise—Bupropion—obesity	0.00139	0.00228	CcSEcCtD
Gallamine Triethiodide—Leukopenia—Bupropion—obesity	0.00138	0.00226	CcSEcCtD
Gallamine Triethiodide—Musculoskeletal discomfort—Orlistat—obesity	0.00136	0.00223	CcSEcCtD
Gallamine Triethiodide—Abdominal discomfort—Topiramate—obesity	0.00135	0.00222	CcSEcCtD
Gallamine Triethiodide—Cough—Bupropion—obesity	0.00134	0.00221	CcSEcCtD
Gallamine Triethiodide—Paraesthesia—Orlistat—obesity	0.00134	0.0022	CcSEcCtD
Gallamine Triethiodide—Pancytopenia—Topiramate—obesity	0.00134	0.0022	CcSEcCtD
Gallamine Triethiodide—Musculoskeletal discomfort—Sibutramine—obesity	0.00131	0.00216	CcSEcCtD
Gallamine Triethiodide—Arthralgia—Bupropion—obesity	0.00131	0.00215	CcSEcCtD
Gallamine Triethiodide—Chest pain—Bupropion—obesity	0.00131	0.00215	CcSEcCtD
Gallamine Triethiodide—Unspecified disorder of skin and subcutaneous tissue—Bupropion—obesity	0.0013	0.00214	CcSEcCtD
Gallamine Triethiodide—Paraesthesia—Sibutramine—obesity	0.00129	0.00213	CcSEcCtD
Gallamine Triethiodide—Gastrointestinal disorder—Orlistat—obesity	0.00128	0.00211	CcSEcCtD
Gallamine Triethiodide—Fatigue—Orlistat—obesity	0.00128	0.00211	CcSEcCtD
Gallamine Triethiodide—Pain—Orlistat—obesity	0.00127	0.00209	CcSEcCtD
Gallamine Triethiodide—Confusional state—Bupropion—obesity	0.00127	0.00208	CcSEcCtD
Gallamine Triethiodide—Gastrointestinal disorder—Sibutramine—obesity	0.00124	0.00204	CcSEcCtD
Gallamine Triethiodide—Pain—Sibutramine—obesity	0.00123	0.00203	CcSEcCtD
Gallamine Triethiodide—Thrombocytopenia—Bupropion—obesity	0.00123	0.00202	CcSEcCtD
Gallamine Triethiodide—Feeling abnormal—Orlistat—obesity	0.00123	0.00202	CcSEcCtD
Gallamine Triethiodide—Tachycardia—Bupropion—obesity	0.00123	0.00202	CcSEcCtD
Gallamine Triethiodide—Skin disorder—Bupropion—obesity	0.00122	0.00201	CcSEcCtD
Gallamine Triethiodide—Feeling abnormal—Sibutramine—obesity	0.00119	0.00195	CcSEcCtD
Gallamine Triethiodide—Urticaria—Orlistat—obesity	0.00118	0.00194	CcSEcCtD
Gallamine Triethiodide—Abdominal pain—Orlistat—obesity	0.00118	0.00193	CcSEcCtD
Gallamine Triethiodide—Body temperature increased—Orlistat—obesity	0.00118	0.00193	CcSEcCtD
Gallamine Triethiodide—Urticaria—Sibutramine—obesity	0.00114	0.00188	CcSEcCtD
Gallamine Triethiodide—Musculoskeletal discomfort—Bupropion—obesity	0.00114	0.00188	CcSEcCtD
Gallamine Triethiodide—Body temperature increased—Sibutramine—obesity	0.00114	0.00187	CcSEcCtD
Gallamine Triethiodide—Abdominal pain—Sibutramine—obesity	0.00114	0.00187	CcSEcCtD
Gallamine Triethiodide—Haemoglobin—Topiramate—obesity	0.00113	0.00186	CcSEcCtD
Gallamine Triethiodide—Rhinitis—Topiramate—obesity	0.00113	0.00186	CcSEcCtD
Gallamine Triethiodide—Paraesthesia—Bupropion—obesity	0.00113	0.00185	CcSEcCtD
Gallamine Triethiodide—Haemorrhage—Topiramate—obesity	0.00113	0.00185	CcSEcCtD
Gallamine Triethiodide—Hypoaesthesia—Topiramate—obesity	0.00112	0.00184	CcSEcCtD
Gallamine Triethiodide—Hypersensitivity—Orlistat—obesity	0.0011	0.0018	CcSEcCtD
Gallamine Triethiodide—Gastrointestinal disorder—Bupropion—obesity	0.00108	0.00178	CcSEcCtD
Gallamine Triethiodide—Fatigue—Bupropion—obesity	0.00108	0.00178	CcSEcCtD
Gallamine Triethiodide—Pain—Bupropion—obesity	0.00107	0.00177	CcSEcCtD
Gallamine Triethiodide—Asthenia—Orlistat—obesity	0.00107	0.00176	CcSEcCtD
Gallamine Triethiodide—Hypersensitivity—Sibutramine—obesity	0.00106	0.00175	CcSEcCtD
Gallamine Triethiodide—Pruritus—Orlistat—obesity	0.00105	0.00173	CcSEcCtD
Gallamine Triethiodide—Eye disorder—Topiramate—obesity	0.00105	0.00173	CcSEcCtD
Gallamine Triethiodide—Cardiac disorder—Topiramate—obesity	0.00105	0.00172	CcSEcCtD
Gallamine Triethiodide—Feeling abnormal—Bupropion—obesity	0.00103	0.0017	CcSEcCtD
Gallamine Triethiodide—Asthenia—Sibutramine—obesity	0.00103	0.0017	CcSEcCtD
Gallamine Triethiodide—Pruritus—Sibutramine—obesity	0.00102	0.00168	CcSEcCtD
Gallamine Triethiodide—Diarrhoea—Orlistat—obesity	0.00102	0.00167	CcSEcCtD
Gallamine Triethiodide—Urticaria—Bupropion—obesity	0.000998	0.00164	CcSEcCtD
Gallamine Triethiodide—Body temperature increased—Bupropion—obesity	0.000993	0.00163	CcSEcCtD
Gallamine Triethiodide—Abdominal pain—Bupropion—obesity	0.000993	0.00163	CcSEcCtD
Gallamine Triethiodide—Diarrhoea—Sibutramine—obesity	0.000986	0.00162	CcSEcCtD
Gallamine Triethiodide—Dysgeusia—Topiramate—obesity	0.00096	0.00158	CcSEcCtD
Gallamine Triethiodide—Vomiting—Orlistat—obesity	0.000946	0.00156	CcSEcCtD
Gallamine Triethiodide—Rash—Orlistat—obesity	0.000938	0.00154	CcSEcCtD
Gallamine Triethiodide—Dermatitis—Orlistat—obesity	0.000938	0.00154	CcSEcCtD
Gallamine Triethiodide—Headache—Orlistat—obesity	0.000932	0.00153	CcSEcCtD
Gallamine Triethiodide—Hypersensitivity—Bupropion—obesity	0.000925	0.00152	CcSEcCtD
Gallamine Triethiodide—Vomiting—Sibutramine—obesity	0.000916	0.00151	CcSEcCtD
Gallamine Triethiodide—Rash—Sibutramine—obesity	0.000908	0.00149	CcSEcCtD
Gallamine Triethiodide—Dermatitis—Sibutramine—obesity	0.000907	0.00149	CcSEcCtD
Gallamine Triethiodide—Anaemia—Topiramate—obesity	0.000906	0.00149	CcSEcCtD
Gallamine Triethiodide—Headache—Sibutramine—obesity	0.000902	0.00148	CcSEcCtD
Gallamine Triethiodide—Asthenia—Bupropion—obesity	0.000901	0.00148	CcSEcCtD
Gallamine Triethiodide—Pruritus—Bupropion—obesity	0.000888	0.00146	CcSEcCtD
Gallamine Triethiodide—Nausea—Orlistat—obesity	0.000884	0.00145	CcSEcCtD
Gallamine Triethiodide—Malaise—Topiramate—obesity	0.000884	0.00145	CcSEcCtD
Gallamine Triethiodide—Leukopenia—Topiramate—obesity	0.000877	0.00144	CcSEcCtD
Gallamine Triethiodide—Diarrhoea—Bupropion—obesity	0.000859	0.00141	CcSEcCtD
Gallamine Triethiodide—Nausea—Sibutramine—obesity	0.000856	0.00141	CcSEcCtD
Gallamine Triethiodide—Cough—Topiramate—obesity	0.000855	0.00141	CcSEcCtD
Gallamine Triethiodide—Arthralgia—Topiramate—obesity	0.000835	0.00137	CcSEcCtD
Gallamine Triethiodide—Chest pain—Topiramate—obesity	0.000835	0.00137	CcSEcCtD
Gallamine Triethiodide—Unspecified disorder of skin and subcutaneous tissue—Topiramate—obesity	0.000829	0.00136	CcSEcCtD
Gallamine Triethiodide—Confusional state—Topiramate—obesity	0.000807	0.00133	CcSEcCtD
Gallamine Triethiodide—Vomiting—Bupropion—obesity	0.000798	0.00131	CcSEcCtD
Gallamine Triethiodide—Rash—Bupropion—obesity	0.000792	0.0013	CcSEcCtD
Gallamine Triethiodide—Dermatitis—Bupropion—obesity	0.000791	0.0013	CcSEcCtD
Gallamine Triethiodide—Headache—Bupropion—obesity	0.000787	0.00129	CcSEcCtD
Gallamine Triethiodide—Thrombocytopenia—Topiramate—obesity	0.000783	0.00129	CcSEcCtD
Gallamine Triethiodide—Tachycardia—Topiramate—obesity	0.000781	0.00128	CcSEcCtD
Gallamine Triethiodide—Skin disorder—Topiramate—obesity	0.000777	0.00128	CcSEcCtD
Gallamine Triethiodide—Nausea—Bupropion—obesity	0.000746	0.00123	CcSEcCtD
Gallamine Triethiodide—Musculoskeletal discomfort—Topiramate—obesity	0.000729	0.0012	CcSEcCtD
Gallamine Triethiodide—Paraesthesia—Topiramate—obesity	0.000718	0.00118	CcSEcCtD
Gallamine Triethiodide—Gastrointestinal disorder—Topiramate—obesity	0.000691	0.00114	CcSEcCtD
Gallamine Triethiodide—Fatigue—Topiramate—obesity	0.00069	0.00113	CcSEcCtD
Gallamine Triethiodide—Pain—Topiramate—obesity	0.000684	0.00112	CcSEcCtD
Gallamine Triethiodide—Feeling abnormal—Topiramate—obesity	0.000659	0.00108	CcSEcCtD
Gallamine Triethiodide—Urticaria—Topiramate—obesity	0.000636	0.00105	CcSEcCtD
Gallamine Triethiodide—Body temperature increased—Topiramate—obesity	0.000632	0.00104	CcSEcCtD
Gallamine Triethiodide—Abdominal pain—Topiramate—obesity	0.000632	0.00104	CcSEcCtD
Gallamine Triethiodide—Hypersensitivity—Topiramate—obesity	0.000589	0.000969	CcSEcCtD
Gallamine Triethiodide—Asthenia—Topiramate—obesity	0.000574	0.000944	CcSEcCtD
Gallamine Triethiodide—Pruritus—Topiramate—obesity	0.000566	0.000931	CcSEcCtD
Gallamine Triethiodide—Diarrhoea—Topiramate—obesity	0.000547	0.0009	CcSEcCtD
Gallamine Triethiodide—Vomiting—Topiramate—obesity	0.000509	0.000836	CcSEcCtD
Gallamine Triethiodide—Rash—Topiramate—obesity	0.000504	0.000829	CcSEcCtD
Gallamine Triethiodide—Dermatitis—Topiramate—obesity	0.000504	0.000829	CcSEcCtD
Gallamine Triethiodide—Headache—Topiramate—obesity	0.000501	0.000824	CcSEcCtD
Gallamine Triethiodide—Nausea—Topiramate—obesity	0.000475	0.000781	CcSEcCtD
Gallamine Triethiodide—CHRM2—Class A/1 (Rhodopsin-like receptors)—POMC—obesity	0.000133	0.000341	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling by GPCR—GLP1R—obesity	0.000133	0.00034	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—PRKAR2B—obesity	0.000131	0.000335	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling by GPCR—CCKAR—obesity	0.000131	0.000334	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling by GPCR—HRH3—obesity	0.000131	0.000334	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR downstream signaling—NPY—obesity	0.000131	0.000333	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Class A/1 (Rhodopsin-like receptors)—CCL2—obesity	0.000131	0.000333	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—DCN—obesity	0.00013	0.000332	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR downstream signaling—IAPP—obesity	0.00013	0.000331	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—APLN—obesity	0.000129	0.000329	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—PYY—obesity	0.000129	0.000329	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism of lipids and lipoproteins—PIK3CG—obesity	0.000128	0.000326	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR ligand binding—HTR2A—obesity	0.000127	0.000325	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR ligand binding—C3—obesity	0.000127	0.000324	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—CPT1A—obesity	0.000127	0.000323	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling by GPCR—PRKAR2B—obesity	0.000126	0.000322	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR downstream signaling—HTR1B—obesity	0.000126	0.000322	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR downstream signaling—CRH—obesity	0.000126	0.000322	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—SIDS Susceptibility Pathways—TNF—obesity	0.000125	0.00032	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism of proteins—AGT—obesity	0.000125	0.000319	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—NAMPT—obesity	0.000124	0.000317	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism of lipids and lipoproteins—PPARG—obesity	0.000123	0.000315	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—LIPC—obesity	0.000123	0.000315	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—GCK—obesity	0.000123	0.000315	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—APOC3—obesity	0.000123	0.000313	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism of proteins—LEP—obesity	0.000122	0.000313	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—PNLIP—obesity	0.000122	0.000311	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism of lipids and lipoproteins—POMC—obesity	0.000122	0.000311	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR ligand binding—AGT—obesity	0.000121	0.000308	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR downstream signaling—NPS—obesity	0.00012	0.000305	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—SDC3—obesity	0.000119	0.000304	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—CETP—obesity	0.000119	0.000304	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling by GPCR—NPY—obesity	0.000119	0.000303	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Regulation of Actin Cytoskeleton—PIK3CA—obesity	0.000119	0.000303	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling by GPCR—IAPP—obesity	0.000118	0.000301	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—SDC1—obesity	0.000118	0.0003	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR downstream signaling—HTR2C—obesity	0.000117	0.000299	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR downstream signaling—DRD1—obesity	0.000117	0.000299	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Integrated Pancreatic Cancer Pathway—AKT1—obesity	0.000117	0.000298	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—NPY5R—obesity	0.000116	0.000297	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—PMCH—obesity	0.000116	0.000297	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—HCRT—obesity	0.000116	0.000297	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—NMU—obesity	0.000116	0.000297	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—AKR1C3—obesity	0.000116	0.000296	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism of proteins—F2—obesity	0.000116	0.000295	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling by GPCR—HTR1B—obesity	0.000114	0.000292	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling by GPCR—CRH—obesity	0.000114	0.000292	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—SCARB1—obesity	0.000114	0.000291	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR downstream signaling—ADRB1—obesity	0.000114	0.00029	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism of lipids and lipoproteins—PIK3CD—obesity	0.000112	0.000287	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—NPY2R—obesity	0.000112	0.000285	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—MC4R—obesity	0.000112	0.000285	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—NPY1R—obesity	0.000112	0.000285	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—MC3R—obesity	0.000112	0.000285	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR ligand binding—F2—obesity	0.000112	0.000285	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR downstream signaling—GHRL—obesity	0.000111	0.000284	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism of lipids and lipoproteins—ALB—obesity	0.000111	0.000283	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—SREBF1—obesity	0.000111	0.000282	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR downstream signaling—DRD4—obesity	0.00011	0.000281	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—PPY—obesity	0.000109	0.000279	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling by GPCR—NPS—obesity	0.000109	0.000277	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—GOT2—obesity	0.000108	0.000275	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—PRKCH—obesity	0.000107	0.000274	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—GIP—obesity	0.000107	0.000274	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—HDAC8—obesity	0.000107	0.000274	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling by GPCR—DRD1—obesity	0.000106	0.000272	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling by GPCR—HTR2C—obesity	0.000106	0.000272	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism of lipids and lipoproteins—PIK3R1—obesity	0.000106	0.000271	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—FASN—obesity	0.000105	0.000269	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR downstream signaling—CNR1—obesity	0.000105	0.000269	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism of proteins—POMC—obesity	0.000105	0.000269	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—BCHE—obesity	0.000105	0.000268	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism of proteins—INS—obesity	0.000105	0.000267	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling by GPCR—ADRB1—obesity	0.000103	0.000263	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism of proteins—CCL2—obesity	0.000103	0.000263	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR downstream signaling—DRD2—obesity	0.000103	0.000262	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—LEPR—obesity	0.000102	0.000261	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR downstream signaling—GCG—obesity	0.000102	0.000259	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR ligand binding—POMC—obesity	0.000102	0.000259	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—CYP2E1—obesity	0.000101	0.000258	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—SIDS Susceptibility Pathways—IL6—obesity	0.000101	0.000258	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism of proteins—IGF1—obesity	0.000101	0.000258	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling by GPCR—GHRL—obesity	0.000101	0.000258	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—NQO1—obesity	0.0001	0.000255	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling by GPCR—DRD4—obesity	0.0001	0.000255	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR ligand binding—CCL2—obesity	9.94e-05	0.000254	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism of lipids and lipoproteins—PIK3CB—obesity	9.8e-05	0.00025	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism of lipids and lipoproteins—PTGS2—obesity	9.71e-05	0.000248	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—SLC2A4—obesity	9.6e-05	0.000245	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—GCG—obesity	9.6e-05	0.000245	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling by GPCR—CNR1—obesity	9.56e-05	0.000244	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—CYCS—obesity	9.47e-05	0.000242	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling by GPCR—DRD2—obesity	9.32e-05	0.000238	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—GOT1—obesity	9.29e-05	0.000237	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—GGT1—obesity	9.29e-05	0.000237	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling by GPCR—GCG—obesity	9.23e-05	0.000236	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR downstream signaling—ADRB2—obesity	9.2e-05	0.000235	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—NCOA1—obesity	9.16e-05	0.000234	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—ADRB3—obesity	9.14e-05	0.000233	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—STK11—obesity	9.02e-05	0.00023	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—CYP19A1—obesity	9.02e-05	0.00023	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—GAL—obesity	8.92e-05	0.000228	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—C5AR1—obesity	8.82e-05	0.000225	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR downstream signaling—GNB3—obesity	8.76e-05	0.000224	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR downstream signaling—GNAS—obesity	8.53e-05	0.000218	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—COMT—obesity	8.39e-05	0.000214	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling by GPCR—ADRB2—obesity	8.35e-05	0.000213	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—PPARGC1A—obesity	8.27e-05	0.000211	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—GNB3—obesity	8.27e-05	0.000211	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—HMOX1—obesity	8.23e-05	0.00021	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR downstream signaling—CCL5—obesity	8.16e-05	0.000208	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—CCK—obesity	8.07e-05	0.000206	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—PRKG1—obesity	8.07e-05	0.000206	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—GNAS—obesity	8.05e-05	0.000206	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling by GPCR—GNB3—obesity	7.95e-05	0.000203	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—APOB—obesity	7.89e-05	0.000201	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—RBP4—obesity	7.87e-05	0.000201	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—GLP1R—obesity	7.87e-05	0.000201	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling by GPCR—GNAS—obesity	7.74e-05	0.000198	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—HRH3—obesity	7.74e-05	0.000197	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—CCKAR—obesity	7.74e-05	0.000197	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—LPL—obesity	7.53e-05	0.000192	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—PRKAR2B—obesity	7.45e-05	0.00019	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling by GPCR—CCL5—obesity	7.41e-05	0.000189	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—GPX1—obesity	7.35e-05	0.000188	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR downstream signaling—PRKCD—obesity	7.35e-05	0.000188	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—NCF2—obesity	7.19e-05	0.000184	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR downstream signaling—HTR2A—obesity	7.19e-05	0.000183	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR downstream signaling—C3—obesity	7.18e-05	0.000183	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—CD36—obesity	7.16e-05	0.000183	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—NPY—obesity	7.01e-05	0.000179	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—IAPP—obesity	6.97e-05	0.000178	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—APOC3—obesity	6.97e-05	0.000178	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR downstream signaling—AGT—obesity	6.82e-05	0.000174	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—MTHFR—obesity	6.78e-05	0.000173	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—CRH—obesity	6.76e-05	0.000173	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—HTR1B—obesity	6.76e-05	0.000173	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—SDC1—obesity	6.69e-05	0.000171	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling by GPCR—PRKCD—obesity	6.67e-05	0.00017	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—PPARA—obesity	6.65e-05	0.00017	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—AKR1C3—obesity	6.58e-05	0.000168	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling by GPCR—HTR2A—obesity	6.53e-05	0.000167	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling by GPCR—C3—obesity	6.52e-05	0.000166	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—AGT—obesity	6.44e-05	0.000164	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—NPS—obesity	6.41e-05	0.000164	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—APOE—obesity	6.31e-05	0.000161	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR downstream signaling—F2—obesity	6.3e-05	0.000161	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR downstream signaling—PRKCB—obesity	6.3e-05	0.000161	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—HTR2C—obesity	6.29e-05	0.00016	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—DRD1—obesity	6.29e-05	0.00016	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—CAV1—obesity	6.25e-05	0.00016	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—APOA1—obesity	6.24e-05	0.000159	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling by GPCR—AGT—obesity	6.2e-05	0.000158	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—NTRK2—obesity	6.12e-05	0.000156	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—ADRB1—obesity	6.09e-05	0.000155	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR downstream signaling—PIK3CG—obesity	6.03e-05	0.000154	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism of lipids and lipoproteins—PIK3CA—obesity	5.98e-05	0.000152	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—PARP1—obesity	5.96e-05	0.000152	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—GHRL—obesity	5.96e-05	0.000152	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—DRD4—obesity	5.91e-05	0.000151	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR downstream signaling—POMC—obesity	5.74e-05	0.000147	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling by GPCR—F2—obesity	5.72e-05	0.000146	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling by GPCR—PRKCB—obesity	5.72e-05	0.000146	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—PIK3CG—obesity	5.7e-05	0.000145	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—CNR1—obesity	5.64e-05	0.000144	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—TCF7L2—obesity	5.55e-05	0.000142	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR downstream signaling—AKT2—obesity	5.52e-05	0.000141	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—DRD2—obesity	5.51e-05	0.000141	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—PPARG—obesity	5.5e-05	0.00014	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling by GPCR—PIK3CG—obesity	5.48e-05	0.00014	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—GCG—obesity	5.45e-05	0.000139	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—PTPN1—obesity	5.45e-05	0.000139	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—POMC—obesity	5.42e-05	0.000138	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—INS—obesity	5.39e-05	0.000138	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR downstream signaling—PIK3CD—obesity	5.3e-05	0.000135	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling by GPCR—POMC—obesity	5.21e-05	0.000133	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—PRL—obesity	5.2e-05	0.000133	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—STK11—obesity	5.13e-05	0.000131	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling by GPCR—CCL2—obesity	5.1e-05	0.00013	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—PLG—obesity	5.07e-05	0.000129	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR downstream signaling—RHOA—obesity	5.06e-05	0.000129	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling by GPCR—AKT2—obesity	5.01e-05	0.000128	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—PIK3CD—obesity	5.01e-05	0.000128	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR downstream signaling—PIK3R1—obesity	5.01e-05	0.000128	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—FOXO3—obesity	4.95e-05	0.000126	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—ALB—obesity	4.94e-05	0.000126	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—ADRB2—obesity	4.93e-05	0.000126	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—SOCS1—obesity	4.86e-05	0.000124	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling by GPCR—PIK3CD—obesity	4.82e-05	0.000123	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—SOCS3—obesity	4.8e-05	0.000122	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—PIK3R1—obesity	4.73e-05	0.000121	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—NOS3—obesity	4.73e-05	0.000121	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—GNB3—obesity	4.7e-05	0.00012	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling by GPCR—TYK2—obesity	4.63e-05	0.000118	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR downstream signaling—PIK3CB—obesity	4.62e-05	0.000118	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—IGF2—obesity	4.62e-05	0.000118	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling by GPCR—RHOA—obesity	4.59e-05	0.000117	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—GNAS—obesity	4.58e-05	0.000117	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling by GPCR—PIK3R1—obesity	4.55e-05	0.000116	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—APOB—obesity	4.48e-05	0.000114	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—CCL5—obesity	4.37e-05	0.000112	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—PIK3CB—obesity	4.37e-05	0.000111	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—PTGS2—obesity	4.33e-05	0.00011	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—LPL—obesity	4.28e-05	0.000109	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—FOXO1—obesity	4.25e-05	0.000108	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—RPS6KB1—obesity	4.24e-05	0.000108	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling by GPCR—PIK3CB—obesity	4.2e-05	0.000107	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—PRKCD—obesity	3.94e-05	0.000101	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—HTR2A—obesity	3.86e-05	9.84e-05	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—C3—obesity	3.85e-05	9.83e-05	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—IRS2—obesity	3.66e-05	9.35e-05	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—AGT—obesity	3.66e-05	9.34e-05	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—LEP—obesity	3.59e-05	9.15e-05	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—APOE—obesity	3.59e-05	9.15e-05	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—CAV1—obesity	3.55e-05	9.07e-05	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—APOA1—obesity	3.54e-05	9.05e-05	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—ESR1—obesity	3.42e-05	8.74e-05	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—F2—obesity	3.38e-05	8.63e-05	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—PRKCB—obesity	3.38e-05	8.63e-05	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—BAD—obesity	3.34e-05	8.53e-05	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—PIK3CG—obesity	3.24e-05	8.26e-05	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—IRS1—obesity	3.2e-05	8.16e-05	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—POMC—obesity	3.08e-05	7.86e-05	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—INS—obesity	3.06e-05	7.82e-05	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—CCL2—obesity	3.01e-05	7.69e-05	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—IGF1—obesity	2.96e-05	7.56e-05	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—AKT2—obesity	2.96e-05	7.56e-05	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—PIK3CD—obesity	2.84e-05	7.26e-05	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR downstream signaling—PIK3CA—obesity	2.82e-05	7.19e-05	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—SERPINE1—obesity	2.81e-05	7.18e-05	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—TYK2—obesity	2.74e-05	6.98e-05	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—RHOA—obesity	2.71e-05	6.93e-05	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—PIK3R1—obesity	2.69e-05	6.86e-05	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—NOS3—obesity	2.69e-05	6.86e-05	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—PIK3CA—obesity	2.66e-05	6.79e-05	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling by GPCR—PIK3CA—obesity	2.56e-05	6.53e-05	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—MTOR—obesity	2.48e-05	6.33e-05	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—PIK3CB—obesity	2.48e-05	6.33e-05	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR downstream signaling—AKT1—obesity	2.3e-05	5.87e-05	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling by GPCR—IL6—obesity	2.27e-05	5.78e-05	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—AKT1—obesity	2.17e-05	5.55e-05	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—MMP9—obesity	2.16e-05	5.5e-05	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—MAPK8—obesity	2.1e-05	5.35e-05	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling by GPCR—AKT1—obesity	2.09e-05	5.33e-05	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—STAT3—obesity	1.92e-05	4.89e-05	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—MYC—obesity	1.78e-05	4.54e-05	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—TGFB1—obesity	1.78e-05	4.53e-05	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—PIK3CA—obesity	1.51e-05	3.86e-05	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—IL6—obesity	1.34e-05	3.42e-05	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—AKT1—obesity	1.23e-05	3.15e-05	CbGpPWpGaD
